Similarities and differences between the effects of EPA and DHA on markers of atherosclerosis in human subjects
DS Kelley, Y Adkins - Proceedings of the Nutrition Society, 2012 - cambridge.org
We have reviewed effects of long chain (LC) n-3 PUFA on markers of atherosclerosis in
human subjects with a focus on individual effects of EPA and DHA. Initial results from …
human subjects with a focus on individual effects of EPA and DHA. Initial results from …
[HTML][HTML] Effect of low doses of long-chain n− 3 PUFAs on endothelial function and arterial stiffness: a randomized controlled trial
TAB Sanders, WL Hall, Z Maniou, F Lewis… - The American journal of …, 2011 - Elsevier
Background: The dietary intake of n− 3 (omega-3) long-chain PUFAs (LC-PUFAs) from fish
may improve endothelial function and arterial stiffness. Objective: The objective was to test …
may improve endothelial function and arterial stiffness. Objective: The objective was to test …
The differential effects of EPA and DHA on cardiovascular risk factors
Compelling evidence exists for the cardioprotective benefits resulting from consumption of
fatty acids from fish oils, EPA (20: 5n-3) and DHA (22: 6n-3). EPA and DHA alter membrane …
fatty acids from fish oils, EPA (20: 5n-3) and DHA (22: 6n-3). EPA and DHA alter membrane …
n-3 PUFA in CVD: influence of cytokine polymorphism
C Von Schacky - Proceedings of the Nutrition Society, 2007 - cambridge.org
In their current guidelines cardiac societies recommend the consumption of the two n-3 fatty
acids EPA and DHA to prevent cardiovascular complications. Cardiovascular events are …
acids EPA and DHA to prevent cardiovascular complications. Cardiovascular events are …
Variability in the Clinical Effects of the Omega-3 Polyunsaturated Fatty Acids DHA and EPA in Cardiovascular Disease—Possible Causes and Future Considerations
Cardiovascular disease (CVD) that includes myocardial infarction and stroke, is the leading
cause of mortality worldwide. Atherosclerosis, the primary underlying cause of CVD, can be …
cause of mortality worldwide. Atherosclerosis, the primary underlying cause of CVD, can be …
Protective role of n6/n3 PUFA supplementation with varying DHA/EPA ratios against atherosclerosis in mice
L Liu, Q Hu, H Wu, Y Xue, L Cai, M Fang, Z Liu… - The Journal of nutritional …, 2016 - Elsevier
The effects of n3 polyunsaturated fatty acids (PUFA) on cardiovascular disease are
controversial. We currently explored the effects of various ratios of docosahexaenoic acid …
controversial. We currently explored the effects of various ratios of docosahexaenoic acid …
Ethnicity, plasma phospholipid fatty acid composition and inflammatory/endothelial activation biomarkers in the Multi-Ethnic Study of Atherosclerosis (MESA)
RESULTS: Chinese adults were found to have the highest mean levels of plasma
eicosapentaenoic acid (EPA, 1.24%) and docosahexaenoic acid (DHA, 4.95%), and the …
eicosapentaenoic acid (EPA, 1.24%) and docosahexaenoic acid (DHA, 4.95%), and the …
[HTML][HTML] (n-3) fatty acids and cardiovascular health: are effects of EPA and DHA shared or complementary?
D Mozaffarian, JHY Wu - The Journal of nutrition, 2012 - Elsevier
Considerable research supports cardiovascular benefits of consuming omega-3 PUFA, also
known as (n-3) PUFA, from fish or fish oil. Whether individual long-chain (n-3) PUFA have …
known as (n-3) PUFA, from fish or fish oil. Whether individual long-chain (n-3) PUFA have …
The effect of EPA and DHA on metabolic syndrome patients: a systematic review of randomised controlled trials
E Lopez-Huertas - British journal of nutrition, 2012 - cambridge.org
Metabolic syndrome (MS) is characterised by accumulation of CVD risk factors. The use of
very long chain n-3 polyunsaturated fatty acids (VLC n3 PUFA) could potentially benefit MS …
very long chain n-3 polyunsaturated fatty acids (VLC n3 PUFA) could potentially benefit MS …
Eicosapentaenoic acid and docosahexaenoic acid regulate modified LDL uptake and macropinocytosis in human macrophages
JE McLaren, DR Michael, IA Guschina, JL Harwood… - Lipids, 2011 - Springer
There is evidence that long chain n-3 PUFA (such as from fish oils) provide atheroprotection
through, in part, changes in macrophage function although it has not been fully determined …
through, in part, changes in macrophage function although it has not been fully determined …